The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Global NGS-based RNA-sequencing Market Research Report 2024

Global NGS-based RNA-sequencing Market Research Report 2024

Publishing Date : Jan, 2024

License Type :
 

Report Code : 1896928

No of Pages : 94

Ask Your Query
Synopsis
Gene expression studies can also involve looking at profiles or patterns of expression of several genes. RNA sequencing (RNA-Seq) leverages the advantages of next-generation sequencing (NGS) to detect and quantify RNA in a biological sample at a given point in time.
The global NGS-based RNA-sequencing market was valued at US$ 2532.5 million in 2023 and is anticipated to reach US$ 7862.7 million by 2030, witnessing a CAGR of 17.4% during the forecast period 2024-2030.
A significant driver in the NGS-based RNA-sequencing market is the increasing demand for comprehensive and high-throughput analysis of RNA molecules for research and clinical applications. Next-generation sequencing (NGS) technology enables researchers to examine gene expression, identify alternative splicing events, and detect RNA modifications at an unprecedented scale. However, a notable challenge in this market is the need for data analysis and storage solutions. Managing the vast amount of data generated by NGS-based RNA-sequencing while ensuring data accuracy, security, and accessibility poses a significant challenge. Bioinformatics tools, cloud-based solutions, and data management strategies must be continually developed to streamline data analysis and storage processes, facilitating the broader adoption of NGS-based RNA-sequencing in genomics research and precision medicine.
This report aims to provide a comprehensive presentation of the global market for NGS-based RNA-sequencing, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding NGS-based RNA-sequencing.
Report Scope
The NGS-based RNA-sequencing market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global NGS-based RNA-sequencing market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the NGS-based RNA-sequencing companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Illumina
Thermo Fischer Scientific
Oxford Nanopore
Agilent Technologies
BGI
PerkinElmer
QIAGEN
Eurofins Scientific
Roche
Takara Bio
GENEWIZ
Hamilton
Macrogen
Zymo Research
Tecan Genomics
Segment by Type
Sequencing by Synthesis
Ion Semiconductor Sequencing
Single-molecule Real-time Sequencing
Nanopore Sequencing
Segment by Application
Research & Academia
Hospitals & Clinics
Pharmaceutical & Biotechnology Companies
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of NGS-based RNA-sequencing companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global NGS-based RNA-sequencing Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Sequencing by Synthesis
1.2.3 Ion Semiconductor Sequencing
1.2.4 Single-molecule Real-time Sequencing
1.2.5 Nanopore Sequencing
1.3 Market by Application
1.3.1 Global NGS-based RNA-sequencing Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Research & Academia
1.3.3 Hospitals & Clinics
1.3.4 Pharmaceutical & Biotechnology Companies
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global NGS-based RNA-sequencing Market Perspective (2019-2030)
2.2 NGS-based RNA-sequencing Growth Trends by Region
2.2.1 Global NGS-based RNA-sequencing Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 NGS-based RNA-sequencing Historic Market Size by Region (2019-2024)
2.2.3 NGS-based RNA-sequencing Forecasted Market Size by Region (2025-2030)
2.3 NGS-based RNA-sequencing Market Dynamics
2.3.1 NGS-based RNA-sequencing Industry Trends
2.3.2 NGS-based RNA-sequencing Market Drivers
2.3.3 NGS-based RNA-sequencing Market Challenges
2.3.4 NGS-based RNA-sequencing Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top NGS-based RNA-sequencing Players by Revenue
3.1.1 Global Top NGS-based RNA-sequencing Players by Revenue (2019-2024)
3.1.2 Global NGS-based RNA-sequencing Revenue Market Share by Players (2019-2024)
3.2 Global NGS-based RNA-sequencing Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by NGS-based RNA-sequencing Revenue
3.4 Global NGS-based RNA-sequencing Market Concentration Ratio
3.4.1 Global NGS-based RNA-sequencing Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by NGS-based RNA-sequencing Revenue in 2023
3.5 NGS-based RNA-sequencing Key Players Head office and Area Served
3.6 Key Players NGS-based RNA-sequencing Product Solution and Service
3.7 Date of Enter into NGS-based RNA-sequencing Market
3.8 Mergers & Acquisitions, Expansion Plans
4 NGS-based RNA-sequencing Breakdown Data by Type
4.1 Global NGS-based RNA-sequencing Historic Market Size by Type (2019-2024)
4.2 Global NGS-based RNA-sequencing Forecasted Market Size by Type (2025-2030)
5 NGS-based RNA-sequencing Breakdown Data by Application
5.1 Global NGS-based RNA-sequencing Historic Market Size by Application (2019-2024)
5.2 Global NGS-based RNA-sequencing Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America NGS-based RNA-sequencing Market Size (2019-2030)
6.2 North America NGS-based RNA-sequencing Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America NGS-based RNA-sequencing Market Size by Country (2019-2024)
6.4 North America NGS-based RNA-sequencing Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe NGS-based RNA-sequencing Market Size (2019-2030)
7.2 Europe NGS-based RNA-sequencing Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe NGS-based RNA-sequencing Market Size by Country (2019-2024)
7.4 Europe NGS-based RNA-sequencing Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific NGS-based RNA-sequencing Market Size (2019-2030)
8.2 Asia-Pacific NGS-based RNA-sequencing Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific NGS-based RNA-sequencing Market Size by Region (2019-2024)
8.4 Asia-Pacific NGS-based RNA-sequencing Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America NGS-based RNA-sequencing Market Size (2019-2030)
9.2 Latin America NGS-based RNA-sequencing Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America NGS-based RNA-sequencing Market Size by Country (2019-2024)
9.4 Latin America NGS-based RNA-sequencing Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa NGS-based RNA-sequencing Market Size (2019-2030)
10.2 Middle East & Africa NGS-based RNA-sequencing Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa NGS-based RNA-sequencing Market Size by Country (2019-2024)
10.4 Middle East & Africa NGS-based RNA-sequencing Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Illumina
11.1.1 Illumina Company Detail
11.1.2 Illumina Business Overview
11.1.3 Illumina NGS-based RNA-sequencing Introduction
11.1.4 Illumina Revenue in NGS-based RNA-sequencing Business (2019-2024)
11.1.5 Illumina Recent Development
11.2 Thermo Fischer Scientific
11.2.1 Thermo Fischer Scientific Company Detail
11.2.2 Thermo Fischer Scientific Business Overview
11.2.3 Thermo Fischer Scientific NGS-based RNA-sequencing Introduction
11.2.4 Thermo Fischer Scientific Revenue in NGS-based RNA-sequencing Business (2019-2024)
11.2.5 Thermo Fischer Scientific Recent Development
11.3 Oxford Nanopore
11.3.1 Oxford Nanopore Company Detail
11.3.2 Oxford Nanopore Business Overview
11.3.3 Oxford Nanopore NGS-based RNA-sequencing Introduction
11.3.4 Oxford Nanopore Revenue in NGS-based RNA-sequencing Business (2019-2024)
11.3.5 Oxford Nanopore Recent Development
11.4 Agilent Technologies
11.4.1 Agilent Technologies Company Detail
11.4.2 Agilent Technologies Business Overview
11.4.3 Agilent Technologies NGS-based RNA-sequencing Introduction
11.4.4 Agilent Technologies Revenue in NGS-based RNA-sequencing Business (2019-2024)
11.4.5 Agilent Technologies Recent Development
11.5 BGI
11.5.1 BGI Company Detail
11.5.2 BGI Business Overview
11.5.3 BGI NGS-based RNA-sequencing Introduction
11.5.4 BGI Revenue in NGS-based RNA-sequencing Business (2019-2024)
11.5.5 BGI Recent Development
11.6 PerkinElmer
11.6.1 PerkinElmer Company Detail
11.6.2 PerkinElmer Business Overview
11.6.3 PerkinElmer NGS-based RNA-sequencing Introduction
11.6.4 PerkinElmer Revenue in NGS-based RNA-sequencing Business (2019-2024)
11.6.5 PerkinElmer Recent Development
11.7 QIAGEN
11.7.1 QIAGEN Company Detail
11.7.2 QIAGEN Business Overview
11.7.3 QIAGEN NGS-based RNA-sequencing Introduction
11.7.4 QIAGEN Revenue in NGS-based RNA-sequencing Business (2019-2024)
11.7.5 QIAGEN Recent Development
11.8 Eurofins Scientific
11.8.1 Eurofins Scientific Company Detail
11.8.2 Eurofins Scientific Business Overview
11.8.3 Eurofins Scientific NGS-based RNA-sequencing Introduction
11.8.4 Eurofins Scientific Revenue in NGS-based RNA-sequencing Business (2019-2024)
11.8.5 Eurofins Scientific Recent Development
11.9 Roche
11.9.1 Roche Company Detail
11.9.2 Roche Business Overview
11.9.3 Roche NGS-based RNA-sequencing Introduction
11.9.4 Roche Revenue in NGS-based RNA-sequencing Business (2019-2024)
11.9.5 Roche Recent Development
11.10 Takara Bio
11.10.1 Takara Bio Company Detail
11.10.2 Takara Bio Business Overview
11.10.3 Takara Bio NGS-based RNA-sequencing Introduction
11.10.4 Takara Bio Revenue in NGS-based RNA-sequencing Business (2019-2024)
11.10.5 Takara Bio Recent Development
11.11 GENEWIZ
11.11.1 GENEWIZ Company Detail
11.11.2 GENEWIZ Business Overview
11.11.3 GENEWIZ NGS-based RNA-sequencing Introduction
11.11.4 GENEWIZ Revenue in NGS-based RNA-sequencing Business (2019-2024)
11.11.5 GENEWIZ Recent Development
11.12 Hamilton
11.12.1 Hamilton Company Detail
11.12.2 Hamilton Business Overview
11.12.3 Hamilton NGS-based RNA-sequencing Introduction
11.12.4 Hamilton Revenue in NGS-based RNA-sequencing Business (2019-2024)
11.12.5 Hamilton Recent Development
11.13 Macrogen
11.13.1 Macrogen Company Detail
11.13.2 Macrogen Business Overview
11.13.3 Macrogen NGS-based RNA-sequencing Introduction
11.13.4 Macrogen Revenue in NGS-based RNA-sequencing Business (2019-2024)
11.13.5 Macrogen Recent Development
11.14 Zymo Research
11.14.1 Zymo Research Company Detail
11.14.2 Zymo Research Business Overview
11.14.3 Zymo Research NGS-based RNA-sequencing Introduction
11.14.4 Zymo Research Revenue in NGS-based RNA-sequencing Business (2019-2024)
11.14.5 Zymo Research Recent Development
11.15 Tecan Genomics
11.15.1 Tecan Genomics Company Detail
11.15.2 Tecan Genomics Business Overview
11.15.3 Tecan Genomics NGS-based RNA-sequencing Introduction
11.15.4 Tecan Genomics Revenue in NGS-based RNA-sequencing Business (2019-2024)
11.15.5 Tecan Genomics Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

Published By : QY Research

Why ‘The Market Reports’

In Business: Pre Sales Support: Post Sales Support: Turn Around Time: Clients Served: Clients Assisted: Client Types: Payment: Partners with: Number of reports: Custom Research: Report Availability: Report Delivery Format: Security:

Payments Accepted From

Connect with us at

Complete Secure Website

SiteLock